Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In individuals with advanced -cell dysfunction, supplementing insulin therapy with pramlintide, the first and currently only approved injectable short-acting selective analog of amylin, has demonstrated efficacy in enhancing both postprandial and overall glycemic control in both type 2 diabetes (T2D) and type 1 diabetes (T1D) without increasing the risk of hypoglycemia or weight gain
Catalytic Activities of DPP4 DPP4 has a post-proline dipeptidyl amino peptidase activity, preferentially cleaving Xaa-Pro dipeptides (where Xaa refers to any amino acid) from oligopeptides
Patients should also continue with healthy eating habits and regular exercise while taking GLP-1
Folic Acid Injection IVThe fast-acting, effective solution for folate deficiency, anemia, pregnancy support, and complete parenteral nutrition
US$ 24.01
US$ 25.13
US$ 20.33
US$ 22.52
US$ 22.01
US$ 25.83
